Cargando…
SUN-273 Diazoxide Use to Limit Weight Gain and Reduce Appetite in a Normoglycaemic Child with Previous Congenital Hyperinsulinism
Diazoxide use to suppress insulin production and achieve weight loss is an area of research interest in obese adults with hyperinsulinaemia, with little success to date. Its use for the purpose of weight management has not, to our knowledge, been described in normoglycaemic children with transient c...
Autores principales: | Ludwig, Karissa, Woodhead, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553078/ http://dx.doi.org/10.1210/js.2019-SUN-273 |
Ejemplares similares
-
SUN-270 Heterozygous Mutation in ABCC8 in a Pedigree with Congenital Hyperinsulinism, Multiple Macrosomic Stillbirths, and Adult-Onset Diabetes Mellitus
por: Ludwig, Karissa, et al.
Publicado: (2019) -
Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism
por: Lee, Cheng-Ting, et al.
Publicado: (2023) -
MON-105 A Case Report of Neonatal Hyperinsulinism in an Infant with Turner Syndrome Successfully Treated with Diazoxide
por: Patterson, Rebecca J, et al.
Publicado: (2020) -
SUN-269 Novel Mutation of the HNF1A Gene in a Patient with Congenital Hyperinsulinism
por: Marinescu, Andreea, et al.
Publicado: (2019) -
SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism
por: Erkin-Cakmak, Ayca, et al.
Publicado: (2020)